Study genes and risk of persistent lung blood pressure in newborns
Part of Genetic & congenital, Lungs & breathing clinical trials.
This study looks at a newborn’s genes (PTGS1 variation) and whether that relates to persistent pulmonary hypertension of the newborn (PPHN), a serious breathing/lung blood-pressure problem. It may help doctors understand who is at higher risk and how to better identify affected babies early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby was born at 34 weeks or later (near-term or full-term)
- Baby has been diagnosed with PPHN (persistent pulmonary hypertension of the newborn)
- The study also includes a comparison group of healthy babies born 34 weeks or later
- Baby does not have lethal birth defects (serious conditions that are not compatible with life)
- Baby should not have certain heart or lung/throat/kidney-like structural problems that could affect breathing, except a PDA or PFO are allowed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic differences to understand why some very low birth-weight babies develop certain health problems. It may help doctors predict risk and tailor care for these babies.
This study looks at what affects outcomes in newborns with high blood pressure in their lungs (pulmonary hypertension). It aims to find factors that predict how well babies do, which could help guide care and improve health.
This trial tests whether giving melatonin to full-term newborns with high blood pressure in their lungs (pulmonary hypertension) can help improve their breathing and oxygen levels. It may offer a new treatment option for babies with this condition.
This study looks at genes that may contribute to pulmonary arterial hypertension (PAH) in people born with certain heart “shunts” (holes between heart chambers). If you have (or your family has) ASD or VSD and PAH confirmed by a heart pressure test, you may be invited to share genetic and health information to help researchers understand risk and better target future care.
This study tests whether changing oxygen targets in preterm infants with high blood pressure in the lungs (pulmonary hypertension) helps their heart and lungs work better. It may help doctors find the best oxygen levels for these babies.
This study looks at the genes that may be linked to pulmonary hypertension. By providing a saliva sample and filling out a health survey from home, you can help researchers learn more about this condition.
Hear when a new Persistent Pulmonary Hypertension of the Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.